Showing results (3161-3170 of 31,410) with videos related to
Sort By:
Pageof 3,141
Journal of Medicinal Chemistry|February 21, 2003
Structure-activity relationship study and drug profile of N-(4-fluorophenylsulfonyl)-L-valyl-L-leucinal (SJA6017) as a potent calpain inhibitorJun Inoue, Masayuki Nakamura, Ying-She Cui, et al.Journal of Medicinal Chemistry|February 7, 1992
2-[(2-pyridylmethyl)sulfinyl]-1H-thieno[3,4-d]imidazoles. A novel class of gastric H+/K(+)-ATPase inhibitorsK Weidmann, A W Herling, H J Lang, et al.Journal of Medicinal Chemistry|May 15, 1992
Synthesis and antiviral activity of 1-cyclobutyl-5-(2-bromovinyl)uracil nucleoside analogues and related compoundsW A Slusarchyk, G S Bisacchi, A K Field, et al.Journal of Medicinal Chemistry|August 7, 1992
Side-chain derivatives of biologically active nucleosides. 1. Side-chain analogs of 3'-azido-3'-deoxythymidine (AZT)J Hiebl, E Zbiral, J Balzarini, et al.Journal of Medicinal Chemistry|June 26, 1992
Synthesis of 3-[(2,3-dihydro-1,1,3-trioxo-1,2-benzisothiazol-2-yl)alkyl] 1,4-dihydropyridine-3,5-dicarboxylate derivatives as calcium channel modulatorsC E Sunkel, M Fau de Casa-Juana, L Santos, et al.Journal of Medicinal Chemistry|June 26, 1992
NMR studies of an FK-506 analog, [U-13C]ascomycin, bound to FK-506-binding proteinA M Petros, G Gemmecker, P Neri, et al.Journal of Medicinal Chemistry|October 30, 1992
Synthesis and dopaminergic activity of some 3-(1,2,3,6-tetrahydro-1-pyridylalkyl)indoles. A novel conformational model to explain structure-activity relationshipsH Böttcher, G Barnickel, H H Hausberg, et al.Journal of Medicinal Chemistry|May 11, 1992
(Aminoalkoxy)chromones. Selective sigma receptor ligandsR H Erickson, K J Natalie, W Bock, et al.Journal of Medicinal Chemistry|May 1, 1992
Substitution on the Phe3 aromatic ring in cyclic delta opioid receptor-selective dermorphin/deltorphin tetrapeptide analogues: electronic and lipophilic requirements for receptor affinityD L Heyl, H I MosbergJournal of Medicinal Chemistry|October 16, 1992
Development of a novel class of cyclic hexapeptide oxytocin antagonists based on a natural productP D Williams, M G Bock, R D Tung, et al.Pageof 3,141